ACT-20 in Patients With Severe COVID-19 Pneumonia
Clinical trial NCT04398303 · UNKNOWN
Trial details
- NCT number
- NCT04398303
- Sponsor
- Aspire Health Science
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-10-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.